Just some good cyber sleuthing by one of our members. Kevetrin efficacy has not been made public officially yet. And yes, the slide was definitely updated. P21 was merely mentioned as an endpoint of the study in a previous slide. I'm sure the company has access to do a little tweaking before they present.
So, only the people who read this board have access to this info and can take advantage of it. They will issue an 8k to handle compliance without issue, but in the meantime, this is trading purely on the acquisition news. When the world finds out about the Kevetrin activation, it explodes imo.
Take advantage of this market inefficiency and load up imo.
Market Data 
Markets 
AI
